Predict your next investment

Sunday Goods company logo

See what CB Insights has to offer

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$7.1M | 3 yrs ago

About Sunday Goods

Sunday Goods is a Scottsdale, AZ-based cannabis cultivator that delivers consumer-facing goods.

Sunday Goods Headquarter Location

7201 E. Camelback Road Suite 350

Scottsdale, Arizona, 85251,

United States

Latest Sunday Goods News

SillaJen begins Pexa-Vec administration in phase 1b melanoma trial in China

Nov 23, 2021

SillaJen begins Pexa-Vec administration in phase 1b melanoma trial in China 바로가기 기자명 Kim Chan-hyuk 닫기 SillaJen said on Tuesday that it started administering Pexa-Vec, an oncolytic virus therapy, in a phase 1b/2 trial to patients with melanoma in China. The Korean biotech firm is conducting the study jointly with its Chinese partner, Lee’s Pharm. The phase 1b study in China will be on 46 patients with advanced or metastatic melanoma who have failed first-line treatment until the second quarter of 2022. SillaJen began administering Pexa-Vec, an oncolytic virus therapy, in a phase 1b/2 trial to patients with melanoma in China. The phase 1b study will be an open-label. Lee’s Pharm plans to divide patients into low-dose Pexa-Vec and high-dose Pexa-Vec groups to decide the dose for a phase 2 trial. Lee’s Pharm plans to evaluate the objective response rate (ORR) and progression-free survival (PFS) of the combination therapy, mixing its PD-L1 drug Socazolimab (code name: ZKAB001) with Pexa-Vec, in patients with advanced melanoma. Socazolimab is an immune checkpoint inhibitor authorized by the Chinese regulator this year. Lee’s Pharm licensed in the drug from Sorrento, a U.S. new drug developer. Lee’s Pharm is testing Socazolimab in various types of cancer, including melanoma, cervical cancer, small-cell lung cancer, and esophageal cancer. SillaJen also said that a phase 2a trial of Pexa-Vec in kidney cancer was progressing smoothly, as patient enrollment was proceeding in Korea and the U.S. The company aims to complete the phase 2a study by next year. “The clinical trial for melanoma has begun in China in earnest. We will make sure we don’t have any glitches,” a SillaJen official said. “We will try our best to promote that Pexa-Vec is the best partner drug for an immune checkpoint inhibitor.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sunday Goods

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sunday Goods is included in 2 Expert Collections, including Wellness Tech.


Wellness Tech

1,219 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.



3,619 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Sunday Goods Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sunday Goods Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.